TWI810239B - 生活習慣病之改善或預防用食品組成物 - Google Patents

生活習慣病之改善或預防用食品組成物 Download PDF

Info

Publication number: TWI810239B
Authority: TW; Taiwan
Prior art keywords: fulvic acid; humic; food composition; acid; mineral
Prior art date: 2018-01-29

Application number

TW108103346A

Other languages

English (en)

Chinese (zh)

Other versions

TW201934021A (zh

Inventor

藤田隆司

詩依羅涼子金川

Original Assignee

日商風格與價值日本股份有限公司

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2018-01-29

Filing date

2019-01-29

Publication date

2023-08-01

2019-01-29 Application filed by 日商風格與價值日本股份有限公司 filed Critical 日商風格與價值日本股份有限公司

2019-09-01 Publication of TW201934021A publication Critical patent/TW201934021A/zh

2023-08-01 Application granted granted Critical

2023-08-01 Publication of TWI810239B publication Critical patent/TWI810239B/zh

Links

239000000203 mixture Substances 0.000 title claims abstract description 57
235000013305 food Nutrition 0.000 title claims abstract description 55
201000010099 disease Diseases 0.000 title claims abstract description 24
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 24
230000006872 improvement Effects 0.000 title claims description 4
230000002265 prevention Effects 0.000 title claims 2
239000002509 fulvic acid Substances 0.000 claims abstract description 83
PUKLDDOGISCFCP-JSQCKWNTSA-N 21-Deoxycortisone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)C)(O)[C@@]1(C)CC2=O PUKLDDOGISCFCP-JSQCKWNTSA-N 0.000 claims abstract description 82
FCYKAQOGGFGCMD-UHFFFAOYSA-N Fulvic acid Natural products O1C2=CC(O)=C(O)C(C(O)=O)=C2C(=O)C2=C1CC(C)(O)OC2 FCYKAQOGGFGCMD-UHFFFAOYSA-N 0.000 claims abstract description 82
229940095100 fulvic acid Drugs 0.000 claims abstract description 82
210000003205 muscle Anatomy 0.000 claims abstract description 31
230000003908 liver function Effects 0.000 claims abstract description 24
239000004480 active ingredient Substances 0.000 claims abstract description 16
230000002438 mitochondrial effect Effects 0.000 claims abstract description 15
230000002929 anti-fatigue Effects 0.000 claims abstract description 14
239000012190 activator Substances 0.000 claims abstract description 11
229910052500 inorganic mineral Inorganic materials 0.000 claims description 64
239000011707 mineral Substances 0.000 claims description 64
238000004519 manufacturing process Methods 0.000 claims description 7
206010012601 diabetes mellitus Diseases 0.000 claims description 6
208000001072 type 2 diabetes mellitus Diseases 0.000 claims description 6
206010006895 Cachexia Diseases 0.000 claims description 5
208000012661 Dyskinesia Diseases 0.000 claims description 5
208000031226 Hyperlipidaemia Diseases 0.000 claims description 5
206010022489 Insulin Resistance Diseases 0.000 claims description 5
208000008589 Obesity Diseases 0.000 claims description 5
235000020824 obesity Nutrition 0.000 claims description 5
208000001076 sarcopenia Diseases 0.000 claims description 5
239000002904 solvent Substances 0.000 claims description 5
239000003864 humus Substances 0.000 claims description 4
208000004930 Fatty Liver Diseases 0.000 claims description 3
206010019708 Hepatic steatosis Diseases 0.000 claims description 3
239000000284 extract Substances 0.000 claims description 3
208000010706 fatty liver disease Diseases 0.000 claims description 3
231100000240 steatosis hepatitis Toxicity 0.000 claims description 3
208000016285 Movement disease Diseases 0.000 claims 1
239000000126 substance Substances 0.000 abstract description 25
238000005728 strengthening Methods 0.000 abstract description 15
235000010755 mineral Nutrition 0.000 description 57
235000009200 high fat diet Nutrition 0.000 description 34
230000000694 effects Effects 0.000 description 27
241000699670 Mus sp. Species 0.000 description 24
238000012360 testing method Methods 0.000 description 23
210000004027 cell Anatomy 0.000 description 15
238000000034 method Methods 0.000 description 15
210000004369 blood Anatomy 0.000 description 13
239000008280 blood Substances 0.000 description 13
238000000605 extraction Methods 0.000 description 10
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 10
150000003839 salts Chemical class 0.000 description 10
210000003470 mitochondria Anatomy 0.000 description 9
210000001700 mitochondrial membrane Anatomy 0.000 description 9
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
230000003213 activating effect Effects 0.000 description 8
150000001720 carbohydrates Chemical class 0.000 description 8
235000014633 carbohydrates Nutrition 0.000 description 8
239000003795 chemical substances by application Substances 0.000 description 8
230000004069 differentiation Effects 0.000 description 8
230000001965 increasing effect Effects 0.000 description 8
238000004458 analytical method Methods 0.000 description 7
239000002689 soil Substances 0.000 description 7
239000000243 solution Substances 0.000 description 7
235000000346 sugar Nutrition 0.000 description 7
210000001519 tissue Anatomy 0.000 description 7
241000699666 Mus <mouse, genus> Species 0.000 description 6
239000002253 acid Substances 0.000 description 6
238000001727 in vivo Methods 0.000 description 6
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
150000007524 organic acids Chemical class 0.000 description 6
238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 5
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
102000004877 Insulin Human genes 0.000 description 5
108090001061 Insulin Proteins 0.000 description 5
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
238000000862 absorption spectrum Methods 0.000 description 5
230000037396 body weight Effects 0.000 description 5
210000000918 epididymis Anatomy 0.000 description 5
201000010063 epididymitis Diseases 0.000 description 5
239000008103 glucose Substances 0.000 description 5
239000004021 humic acid Substances 0.000 description 5
229940125396 insulin Drugs 0.000 description 5
230000037356 lipid metabolism Effects 0.000 description 5
210000004185 liver Anatomy 0.000 description 5
238000002360 preparation method Methods 0.000 description 5
230000001737 promoting effect Effects 0.000 description 5
238000003756 stirring Methods 0.000 description 5
QJZYHAIUNVAGQP-UHFFFAOYSA-N 3-nitrobicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid Chemical compound C1C2C=CC1C(C(=O)O)C2(C(O)=O)[N+]([O-])=O QJZYHAIUNVAGQP-UHFFFAOYSA-N 0.000 description 4
241000894006 Bacteria Species 0.000 description 4
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
235000001014 amino acid Nutrition 0.000 description 4
150000001413 amino acids Chemical class 0.000 description 4
238000009534 blood test Methods 0.000 description 4
238000007796 conventional method Methods 0.000 description 4
238000007446 glucose tolerance test Methods 0.000 description 4
238000000338 in vitro Methods 0.000 description 4
239000000843 powder Substances 0.000 description 4
235000015067 sauces Nutrition 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
241000196324 Embryophyta Species 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
101000906283 Homo sapiens Solute carrier family 2, facilitated glucose transporter member 1 Proteins 0.000 description 3
OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
102000005604 Myosin Heavy Chains Human genes 0.000 description 3
108010084498 Myosin Heavy Chains Proteins 0.000 description 3
MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
102100023536 Solute carrier family 2, facilitated glucose transporter member 1 Human genes 0.000 description 3
230000009471 action Effects 0.000 description 3
210000001789 adipocyte Anatomy 0.000 description 3
239000003513 alkali Substances 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
235000015872 dietary supplement Nutrition 0.000 description 3
238000002189 fluorescence spectrum Methods 0.000 description 3
230000004907 flux Effects 0.000 description 3
239000003112 inhibitor Substances 0.000 description 3
239000004310 lactic acid Substances 0.000 description 3
235000014655 lactic acid Nutrition 0.000 description 3
239000007788 liquid Substances 0.000 description 3
238000005259 measurement Methods 0.000 description 3
230000004060 metabolic process Effects 0.000 description 3
238000002156 mixing Methods 0.000 description 3
210000000663 muscle cell Anatomy 0.000 description 3
230000003287 optical effect Effects 0.000 description 3
235000005985 organic acids Nutrition 0.000 description 3
239000005416 organic matter Substances 0.000 description 3
230000002093 peripheral effect Effects 0.000 description 3
239000000047 product Substances 0.000 description 3
235000018102 proteins Nutrition 0.000 description 3
102000004169 proteins and genes Human genes 0.000 description 3
108090000623 proteins and genes Proteins 0.000 description 3
230000002829 reductive effect Effects 0.000 description 3
238000000926 separation method Methods 0.000 description 3
235000014347 soups Nutrition 0.000 description 3
239000006228 supernatant Substances 0.000 description 3
235000019786 weight gain Nutrition 0.000 description 3
HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
231100000582 ATP assay Toxicity 0.000 description 2
238000011814 C57BL/6N mouse Methods 0.000 description 2
108010092160 Dactinomycin Proteins 0.000 description 2
QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
206010020772 Hypertension Diseases 0.000 description 2
108010059343 MM Form Creatine Kinase Proteins 0.000 description 2
241000124008 Mammalia Species 0.000 description 2
AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
244000294411 Mirabilis expansa Species 0.000 description 2
235000015429 Mirabilis expansa Nutrition 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
244000299461 Theobroma cacao Species 0.000 description 2
238000010521 absorption reaction Methods 0.000 description 2
238000009825 accumulation Methods 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
229930183665 actinomycin Natural products 0.000 description 2
210000000577 adipose tissue Anatomy 0.000 description 2
229920006125 amorphous polymer Polymers 0.000 description 2
238000003556 assay Methods 0.000 description 2
238000003149 assay kit Methods 0.000 description 2
238000011888 autopsy Methods 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
235000015895 biscuits Nutrition 0.000 description 2
235000009508 confectionery Nutrition 0.000 description 2
239000006071 cream Substances 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
230000013872 defecation Effects 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
235000011850 desserts Nutrition 0.000 description 2
238000010586 diagram Methods 0.000 description 2
XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
239000003814 drug Substances 0.000 description 2
235000006694 eating habits Nutrition 0.000 description 2
230000005284 excitation Effects 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
239000000706 filtrate Substances 0.000 description 2
235000011194 food seasoning agent Nutrition 0.000 description 2
238000004508 fractional distillation Methods 0.000 description 2
230000006870 function Effects 0.000 description 2
235000013376 functional food Nutrition 0.000 description 2
239000003365 glass fiber Substances 0.000 description 2
239000008187 granular material Substances 0.000 description 2
235000013402 health food Nutrition 0.000 description 2
208000013403 hyperactivity Diseases 0.000 description 2
235000015243 ice cream Nutrition 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 2
230000037353 metabolic pathway Effects 0.000 description 2
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
244000005700 microbiome Species 0.000 description 2
235000013536 miso Nutrition 0.000 description 2
230000004898 mitochondrial function Effects 0.000 description 2
235000021590 normal diet Nutrition 0.000 description 2
235000016709 nutrition Nutrition 0.000 description 2
238000007410 oral glucose tolerance test Methods 0.000 description 2
230000003449 preventive effect Effects 0.000 description 2
238000000746 purification Methods 0.000 description 2
239000008213 purified water Substances 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
238000000638 solvent extraction Methods 0.000 description 2
230000035882 stress Effects 0.000 description 2
210000003699 striated muscle Anatomy 0.000 description 2
210000002820 sympathetic nervous system Anatomy 0.000 description 2
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
230000004584 weight gain Effects 0.000 description 2
208000016261 weight loss Diseases 0.000 description 2
235000014101 wine Nutrition 0.000 description 2
MNULEGDCPYONBU-WMBHJXFZSA-N (1r,4s,5e,5'r,6'r,7e,10s,11r,12s,14r,15s,16s,18r,19s,20r,21e,25s,26r,27s,29s)-4-ethyl-11,12,15,19-tetrahydroxy-6'-[(2s)-2-hydroxypropyl]-5',10,12,14,16,18,20,26,29-nonamethylspiro[24,28-dioxabicyclo[23.3.1]nonacosa-5,7,21-triene-27,2'-oxane]-13,17,23-trio Polymers O([C@@H]1CC[C@@H](/C=C/C=C/C[C@H](C)[C@@H](O)[C@](C)(O)C(=O)[C@H](C)[C@@H](O)[C@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)/C=C/C(=O)O[C@H]([C@H]2C)[C@H]1C)CC)[C@]12CC[C@@H](C)[C@@H](C[C@H](C)O)O1 MNULEGDCPYONBU-WMBHJXFZSA-N 0.000 description 1
MNULEGDCPYONBU-DJRUDOHVSA-N (1s,4r,5z,5'r,6'r,7e,10s,11r,12s,14r,15s,18r,19r,20s,21e,26r,27s)-4-ethyl-11,12,15,19-tetrahydroxy-6'-(2-hydroxypropyl)-5',10,12,14,16,18,20,26,29-nonamethylspiro[24,28-dioxabicyclo[23.3.1]nonacosa-5,7,21-triene-27,2'-oxane]-13,17,23-trione Polymers O([C@H]1CC[C@H](\C=C/C=C/C[C@H](C)[C@@H](O)[C@](C)(O)C(=O)[C@H](C)[C@@H](O)C(C)C(=O)[C@H](C)[C@H](O)[C@@H](C)/C=C/C(=O)OC([C@H]2C)C1C)CC)[C@]12CC[C@@H](C)[C@@H](CC(C)O)O1 MNULEGDCPYONBU-DJRUDOHVSA-N 0.000 description 1
MNULEGDCPYONBU-YNZHUHFTSA-N (4Z,18Z,20Z)-22-ethyl-7,11,14,15-tetrahydroxy-6'-(2-hydroxypropyl)-5',6,8,10,12,14,16,28,29-nonamethylspiro[2,26-dioxabicyclo[23.3.1]nonacosa-4,18,20-triene-27,2'-oxane]-3,9,13-trione Polymers CC1C(C2C)OC(=O)\C=C/C(C)C(O)C(C)C(=O)C(C)C(O)C(C)C(=O)C(C)(O)C(O)C(C)C\C=C/C=C\C(CC)CCC2OC21CCC(C)C(CC(C)O)O2 MNULEGDCPYONBU-YNZHUHFTSA-N 0.000 description 1
AKYHKWQPZHDOBW-UHFFFAOYSA-N (5-ethenyl-1-azabicyclo[2.2.2]octan-7-yl)-(6-methoxyquinolin-4-yl)methanol Chemical compound OS(O)(=O)=O.C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 AKYHKWQPZHDOBW-UHFFFAOYSA-N 0.000 description 1
MNULEGDCPYONBU-VVXVDZGXSA-N (5e,5'r,7e,10s,11r,12s,14s,15r,16r,18r,19s,20r,21e,26r,29s)-4-ethyl-11,12,15,19-tetrahydroxy-6'-[(2s)-2-hydroxypropyl]-5',10,12,14,16,18,20,26,29-nonamethylspiro[24,28-dioxabicyclo[23.3.1]nonacosa-5,7,21-triene-27,2'-oxane]-13,17,23-trione Polymers C([C@H](C)[C@@H](O)[C@](C)(O)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)/C=C/C(=O)OC([C@H]1C)[C@H]2C)\C=C\C=C\C(CC)CCC2OC21CC[C@@H](C)C(C[C@H](C)O)O2 MNULEGDCPYONBU-VVXVDZGXSA-N 0.000 description 1
BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
MNULEGDCPYONBU-UHFFFAOYSA-N 4-ethyl-11,12,15,19-tetrahydroxy-6'-(2-hydroxypropyl)-5',10,12,14,16,18,20,26,29-nonamethylspiro[24,28-dioxabicyclo[23.3.1]nonacosa-5,7,21-triene-27,2'-oxane]-13,17,23-trione Polymers CC1C(C2C)OC(=O)C=CC(C)C(O)C(C)C(=O)C(C)C(O)C(C)C(=O)C(C)(O)C(O)C(C)CC=CC=CC(CC)CCC2OC21CCC(C)C(CC(C)O)O2 MNULEGDCPYONBU-UHFFFAOYSA-N 0.000 description 1
230000002407 ATP formation Effects 0.000 description 1
229940126565 ATP-synthase inhibitor Drugs 0.000 description 1
108010076365 Adiponectin Proteins 0.000 description 1
102000011690 Adiponectin Human genes 0.000 description 1
208000024827 Alzheimer disease Diseases 0.000 description 1
UIFFUZWRFRDZJC-UHFFFAOYSA-N Antimycin A1 Natural products CC1OC(=O)C(CCCCCC)C(OC(=O)CC(C)C)C(C)OC(=O)C1NC(=O)C1=CC=CC(NC=O)=C1O UIFFUZWRFRDZJC-UHFFFAOYSA-N 0.000 description 1
NQWZLRAORXLWDN-UHFFFAOYSA-N Antimycin-A Natural products CCCCCCC(=O)OC1C(C)OC(=O)C(NC(=O)c2ccc(NC=O)cc2O)C(C)OC(=O)C1CCCC NQWZLRAORXLWDN-UHFFFAOYSA-N 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical class [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
BMZRVOVNUMQTIN-UHFFFAOYSA-N Carbonyl Cyanide para-Trifluoromethoxyphenylhydrazone Chemical compound FC(F)(F)OC1=CC=C(NN=C(C#N)C#N)C=C1 BMZRVOVNUMQTIN-UHFFFAOYSA-N 0.000 description 1
101000957724 Catostomus commersonii Corticoliberin-1 Proteins 0.000 description 1
208000028698 Cognitive impairment Diseases 0.000 description 1
241001137251 Corvidae Species 0.000 description 1
201000004624 Dermatitis Diseases 0.000 description 1
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
238000008157 ELISA kit Methods 0.000 description 1
239000004278 EU approved seasoning Substances 0.000 description 1
239000001576 FEMA 2977 Substances 0.000 description 1
108091052347 Glucose transporter family Proteins 0.000 description 1
102000042092 Glucose transporter family Human genes 0.000 description 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
241001559542 Hippocampus hippocampus Species 0.000 description 1
206010021143 Hypoxia Diseases 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical class C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
108010028554 LDL Cholesterol Proteins 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical class [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
101000775476 Mus musculus Adiponectin Proteins 0.000 description 1
101100054965 Mus musculus Adipoq gene Proteins 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
241000237502 Ostreidae Species 0.000 description 1
229930040373 Paraformaldehyde Natural products 0.000 description 1
235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
235000011613 Pinus brutia Nutrition 0.000 description 1
241000018646 Pinus brutia Species 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical class [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
238000011529 RT qPCR Methods 0.000 description 1
206010057190 Respiratory tract infections Diseases 0.000 description 1
241000736285 Sphagnum Species 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
238000000692 Student's t-test Methods 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
244000269722 Thea sinensis Species 0.000 description 1
235000009470 Theobroma cacao Nutrition 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
235000011054 acetic acid Nutrition 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000004913 activation Effects 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
210000004100 adrenal gland Anatomy 0.000 description 1
230000032683 aging Effects 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
239000012670 alkaline solution Substances 0.000 description 1
BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical class [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
150000003863 ammonium salts Chemical class 0.000 description 1
230000003110 anti-inflammatory effect Effects 0.000 description 1
UIFFUZWRFRDZJC-SBOOETFBSA-N antimycin A Chemical compound C[C@H]1OC(=O)[C@H](CCCCCC)[C@@H](OC(=O)CC(C)C)[C@H](C)OC(=O)[C@H]1NC(=O)C1=CC=CC(NC=O)=C1O UIFFUZWRFRDZJC-SBOOETFBSA-N 0.000 description 1
PVEVXUMVNWSNIG-UHFFFAOYSA-N antimycin A3 Natural products CC1OC(=O)C(CCCC)C(OC(=O)CC(C)C)C(C)OC(=O)C1NC(=O)C1=CC=CC(NC=O)=C1O PVEVXUMVNWSNIG-UHFFFAOYSA-N 0.000 description 1
239000002246 antineoplastic agent Substances 0.000 description 1
235000019789 appetite Nutrition 0.000 description 1
230000036528 appetite Effects 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
208000010668 atopic eczema Diseases 0.000 description 1
235000015241 bacon Nutrition 0.000 description 1
239000002585 base Substances 0.000 description 1
235000015278 beef Nutrition 0.000 description 1
230000006399 behavior Effects 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
235000013361 beverage Nutrition 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
235000012970 cakes Nutrition 0.000 description 1
239000011575 calcium Chemical class 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
239000002775 capsule Substances 0.000 description 1
235000014171 carbonated beverage Nutrition 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
230000000747 cardiac effect Effects 0.000 description 1
230000024245 cell differentiation Effects 0.000 description 1
230000003915 cell function Effects 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
230000008859 change Effects 0.000 description 1
235000013351 cheese Nutrition 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
229940112822 chewing gum Drugs 0.000 description 1
235000015218 chewing gum Nutrition 0.000 description 1
235000019219 chocolate Nutrition 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
239000003245 coal Substances 0.000 description 1
235000016213 coffee Nutrition 0.000 description 1
235000013353 coffee beverage Nutrition 0.000 description 1
208000010877 cognitive disease Diseases 0.000 description 1
239000002826 coolant Substances 0.000 description 1
239000000287 crude extract Substances 0.000 description 1
238000002425 crystallisation Methods 0.000 description 1
230000008025 crystallization Effects 0.000 description 1
235000021438 curry Nutrition 0.000 description 1
231100000135 cytotoxicity Toxicity 0.000 description 1
230000003013 cytotoxicity Effects 0.000 description 1
235000013365 dairy product Nutrition 0.000 description 1
238000000354 decomposition reaction Methods 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
238000007598 dipping method Methods 0.000 description 1
239000007884 disintegrant Substances 0.000 description 1
238000004821 distillation Methods 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
231100000673 dose–response relationship Toxicity 0.000 description 1
235000012489 doughnuts Nutrition 0.000 description 1
230000035622 drinking Effects 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000000975 dye Substances 0.000 description 1
230000000667 effect on insulin Effects 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
235000004626 essential fatty acids Nutrition 0.000 description 1
CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
235000021107 fermented food Nutrition 0.000 description 1
238000001914 filtration Methods 0.000 description 1
229930003935 flavonoid Natural products 0.000 description 1
150000002215 flavonoids Chemical class 0.000 description 1
235000017173 flavonoids Nutrition 0.000 description 1
235000003599 food sweetener Nutrition 0.000 description 1
235000019253 formic acid Nutrition 0.000 description 1
238000005194 fractionation Methods 0.000 description 1
235000015203 fruit juice Nutrition 0.000 description 1
235000019990 fruit wine Nutrition 0.000 description 1
239000001530 fumaric acid Substances 0.000 description 1
235000011087 fumaric acid Nutrition 0.000 description 1
125000000524 functional group Chemical group 0.000 description 1
230000004190 glucose uptake Effects 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
230000036541 health Effects 0.000 description 1
230000007407 health benefit Effects 0.000 description 1
229910001385 heavy metal Inorganic materials 0.000 description 1
238000005534 hematocrit Methods 0.000 description 1
238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 1
210000004408 hybridoma Anatomy 0.000 description 1
150000004677 hydrates Chemical class 0.000 description 1
XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
229940071870 hydroiodic acid Drugs 0.000 description 1
230000007954 hypoxia Effects 0.000 description 1
238000007654 immersion Methods 0.000 description 1
238000003364 immunohistochemistry Methods 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
239000003456 ion exchange resin Substances 0.000 description 1
229920003303 ion-exchange polymer Polymers 0.000 description 1
235000015110 jellies Nutrition 0.000 description 1
239000008274 jelly Substances 0.000 description 1
235000008960 ketchup Nutrition 0.000 description 1
238000002386 leaching Methods 0.000 description 1
238000000622 liquid--liquid extraction Methods 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
238000004020 luminiscence type Methods 0.000 description 1
239000011777 magnesium Chemical class 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
239000011976 maleic acid Substances 0.000 description 1
239000001630 malic acid Substances 0.000 description 1
235000011090 malic acid Nutrition 0.000 description 1
235000013372 meat Nutrition 0.000 description 1
230000010534 mechanism of action Effects 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
239000012528 membrane Substances 0.000 description 1
231100000783 metal toxicity Toxicity 0.000 description 1
229940098779 methanesulfonic acid Drugs 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
238000000386 microscopy Methods 0.000 description 1
238000000874 microwave-assisted extraction Methods 0.000 description 1
235000020124 milk-based beverage Nutrition 0.000 description 1
150000007522 mineralic acids Chemical class 0.000 description 1
230000006540 mitochondrial respiration Effects 0.000 description 1
238000012806 monitoring device Methods 0.000 description 1
229940028444 muse Drugs 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
229910017604 nitric acid Inorganic materials 0.000 description 1
150000007523 nucleic acids Chemical class 0.000 description 1
102000039446 nucleic acids Human genes 0.000 description 1
108020004707 nucleic acids Proteins 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
230000035764 nutrition Effects 0.000 description 1
229930191479 oligomycin Natural products 0.000 description 1
MNULEGDCPYONBU-AWJDAWNUSA-N oligomycin A Polymers O([C@H]1CC[C@H](/C=C/C=C/C[C@@H](C)[C@H](O)[C@@](C)(O)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@@H](C)[C@H](O)[C@@H](C)/C=C/C(=O)O[C@@H]([C@@H]2C)[C@@H]1C)CC)[C@@]12CC[C@H](C)[C@H](C[C@@H](C)O)O1 MNULEGDCPYONBU-AWJDAWNUSA-N 0.000 description 1
150000007530 organic bases Chemical class 0.000 description 1
229920000620 organic polymer Polymers 0.000 description 1
235000006408 oxalic acid Nutrition 0.000 description 1
230000036542 oxidative stress Effects 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
230000036284 oxygen consumption Effects 0.000 description 1
235000020636 oyster Nutrition 0.000 description 1
210000000496 pancreas Anatomy 0.000 description 1
239000012188 paraffin wax Substances 0.000 description 1
229920002866 paraformaldehyde Polymers 0.000 description 1
235000015927 pasta Nutrition 0.000 description 1
238000010827 pathological analysis Methods 0.000 description 1
239000002304 perfume Substances 0.000 description 1
230000002572 peristaltic effect Effects 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
235000021110 pickles Nutrition 0.000 description 1
235000015108 pies Nutrition 0.000 description 1
239000000049 pigment Substances 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
150000008442 polyphenolic compounds Chemical class 0.000 description 1
235000013824 polyphenols Nutrition 0.000 description 1
239000011591 potassium Chemical class 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000002335 preservative effect Effects 0.000 description 1
238000004393 prognosis Methods 0.000 description 1
BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
235000019260 propionic acid Nutrition 0.000 description 1
GMVPRGQOIOIIMI-DWKJAMRDSA-N prostaglandin E1 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DWKJAMRDSA-N 0.000 description 1
238000002731 protein assay Methods 0.000 description 1
235000011962 puddings Nutrition 0.000 description 1
229940107700 pyruvic acid Drugs 0.000 description 1
238000011002 quantification Methods 0.000 description 1
IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
229960003110 quinine sulfate Drugs 0.000 description 1
150000004053 quinones Chemical class 0.000 description 1
239000002994 raw material Substances 0.000 description 1
238000011084 recovery Methods 0.000 description 1
238000001953 recrystallisation Methods 0.000 description 1
238000011160 research Methods 0.000 description 1
239000011347 resin Substances 0.000 description 1
229920005989 resin Polymers 0.000 description 1
230000000241 respiratory effect Effects 0.000 description 1
230000029058 respiratory gaseous exchange Effects 0.000 description 1
230000004044 response Effects 0.000 description 1
238000001223 reverse osmosis Methods 0.000 description 1
238000012552 review Methods 0.000 description 1
229940080817 rotenone Drugs 0.000 description 1
JUVIOZPCNVVQFO-UHFFFAOYSA-N rotenone Natural products O1C2=C3CC(C(C)=C)OC3=CC=C2C(=O)C2C1COC1=C2C=C(OC)C(OC)=C1 JUVIOZPCNVVQFO-UHFFFAOYSA-N 0.000 description 1
235000014438 salad dressings Nutrition 0.000 description 1
238000005070 sampling Methods 0.000 description 1
235000013580 sausages Nutrition 0.000 description 1
239000002002 slurry Substances 0.000 description 1
230000000391 smoking effect Effects 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000007787 solid Substances 0.000 description 1
238000000956 solid--liquid extraction Methods 0.000 description 1
239000012453 solvate Substances 0.000 description 1
235000013555 soy sauce Nutrition 0.000 description 1
238000002798 spectrophotometry method Methods 0.000 description 1
230000002269 spontaneous effect Effects 0.000 description 1
235000011496 sports drink Nutrition 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
239000010421 standard material Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
239000008107 starch Substances 0.000 description 1
238000007619 statistical method Methods 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
238000000194 supercritical-fluid extraction Methods 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
238000013268 sustained release Methods 0.000 description 1
239000012730 sustained-release form Substances 0.000 description 1
239000003765 sweetening agent Substances 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
239000003826 tablet Substances 0.000 description 1
239000011975 tartaric acid Substances 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1
235000013616 tea Nutrition 0.000 description 1
239000012085 test solution Substances 0.000 description 1
230000036962 time dependent Effects 0.000 description 1
239000011573 trace mineral Substances 0.000 description 1
235000013619 trace mineral Nutrition 0.000 description 1
238000012546 transfer Methods 0.000 description 1
235000019583 umami taste Nutrition 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
230000004580 weight loss Effects 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1
235000008924 yoghurt drink Nutrition 0.000 description 1
235000013618 yogurt Nutrition 0.000 description 1

Images

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Cardiology (AREA)
Neurology (AREA)
Endocrinology (AREA)
Heart & Thoracic Surgery (AREA)
Mycology (AREA)
Nutrition Science (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Child & Adolescent Psychology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Medicines Containing Plant Substances (AREA)

TW108103346A 2018-01-29 2019-01-29 生活習慣病之改善或預防用食品組成物 TWI810239B (zh)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2018012270		2018-01-29
JP2018-012270		2018-01-29

Publications (2)

Publication Number	Publication Date
TW201934021A TW201934021A (zh)	2019-09-01
TWI810239B true TWI810239B (zh)	2023-08-01

Family

ID=67395001

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW108103346A TWI810239B (zh)	2018-01-29	2019-01-29	生活習慣病之改善或預防用食品組成物

Country Status (3)

Country	Link
JP (1)	JP7038424B2 (fr)
TW (1)	TWI810239B (fr)
WO (1)	WO2019146790A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2021042151A (ja) *	2019-09-10	2021-03-18	株式会社東洋新薬	皮脂の産生又は蓄積抑制剤、角化異常の予防又は改善剤、ニキビの予防又は改善剤
JP2022108114A (ja) *	2021-01-12	2022-07-25	株式会社スタイルアンドバリュージャパン	オートファジー誘導剤

Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101744844A (zh) *	2009-12-14	2010-06-23	昆明理工大学	具有降血糖作用的黄腐酸或黄腐酸钠物质
KR20120108797A (ko) *	2011-03-25	2012-10-05	허교	활성물질로 풀빅산을 포함하는 간질환 치료용 조성물
JP2013032298A (ja) *	2011-08-01	2013-02-14	Kinki Univ	海洋性腐植土の水性溶媒抽出物とその用途
WO2015179675A1 (fr) *	2014-05-21	2015-11-26	Natreon, Inc.	Compositions contenant du chrome pour améliorer la fonction endothéliale et la santé cardiovasculaire
JP2017530980A (ja) *	2014-10-02	2017-10-19	ナトレオン，インコーポレイテッド	シラジット（ｓｈｉｌａｊｉｔ）の使用による筋肉の増強および修復の促進と、コラーゲンおよび関係するタンパク質に関連する障害の処置

2019
- 2019-01-28 WO PCT/JP2019/002820 patent/WO2019146790A1/fr not_active Ceased
- 2019-01-28 JP JP2019567210A patent/JP7038424B2/ja active Active
- 2019-01-29 TW TW108103346A patent/TWI810239B/zh active

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101744844A (zh) *	2009-12-14	2010-06-23	昆明理工大学	具有降血糖作用的黄腐酸或黄腐酸钠物质
KR20120108797A (ko) *	2011-03-25	2012-10-05	허교	활성물질로 풀빅산을 포함하는 간질환 치료용 조성물
JP2013032298A (ja) *	2011-08-01	2013-02-14	Kinki Univ	海洋性腐植土の水性溶媒抽出物とその用途
WO2015179675A1 (fr) *	2014-05-21	2015-11-26	Natreon, Inc.	Compositions contenant du chrome pour améliorer la fonction endothéliale et la santé cardiovasculaire
JP2017530980A (ja) *	2014-10-02	2017-10-19	ナトレオン，インコーポレイテッド	シラジット（ｓｈｉｌａｊｉｔ）の使用による筋肉の増強および修復の促進と、コラーゲンおよび関係するタンパク質に関連する障害の処置

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
網路文獻 STOHS, Sidney J. et al., "Safety and Efficacy of Shilajit (Mumie, Moomiyo), Phytother Res, 2014, vol. 28, pages 475-479. *

Also Published As

Publication number	Publication date
JPWO2019146790A1 (ja)	2021-01-14
JP7038424B2 (ja)	2022-03-18
TW201934021A (zh)	2019-09-01
WO2019146790A1 (fr)	2019-08-01

Publication	Publication Date	Title
Komarnytsky et al.	2011	Potato protease inhibitors inhibit food intake and increase circulating cholecystokinin levels by a trypsin-dependent mechanism
EP2251024A1 (fr)	2010-11-17	Médicament d'origine végétale destiné à prévenir ou améliorer l'hyperuricémie
JP2014037399A (ja)	2014-02-27	抗糖化剤およびその製造方法
TWI810239B (zh)	2023-08-01	生活習慣病之改善或預防用食品組成物
JP2025170060A (ja)	2025-11-14	血小板由来成長因子（ｐｄｇｆ）－ｂｂ産生亢進剤、及びそれを含む幹細胞安定化剤、並びにそれらを含む皮膚抗老化剤
Li et al.	2023	L-quebrachitol extracted from industrial rubber serum: a study on its antioxidant activities and bone mineral density enhancing functions
WO2022220265A1 (fr)	2022-10-20	Activateur ou amplificateur d'expression des sirtuines ou de klotho, agent d'augmentation du nad+, et agent sénolytique
JP2020083815A (ja)	2020-06-04	アミロイドβ凝集阻害剤組成物、ＢＡＣＥ１阻害剤組成物及びそれらを含む抗アルツハイマー組成物
WO2019031442A1 (fr)	2019-02-14	Agent améliorant la circulation sanguine
JP7843342B2 (ja)	2026-04-09	ｅＮＡＭＰＴ増加剤、サーチュイン活性化又は発現増強剤、ＮＡＤ＋増加剤、及び老化細胞抑制剤
Tsuji et al.	2020	Treatment with indigo plant (Polygonum tinctorium Lour) improves serum lipid profiles in Wistar rats fed a high-fat diet
JP7373622B2 (ja)	2023-11-02	筋萎縮を阻害するための組成物、及び、筋萎縮原因遺伝子の発現を抑制するための組成物
CA3003378C (fr)	2021-03-30	Derives d'acide citrique contre les troubles hepatiques
KR100971039B1 (ko)	2010-07-20	복분자 추출물을 함유하는 골다공증 예방 또는 치료용조성물
KR101515842B1 (ko)	2015-04-29	해양심층수의 미네랄추출물을 유효성분으로 함유하는 고혈당 및 비만형 제2형 당뇨 예방 및 치료용 약학적 조성물
JP6058872B2 (ja)	2017-01-11	抗ストレス作用を有するｇａｂａ高含有トマト由来組成物
JP5294194B2 (ja)	2013-09-18	脳血管性認知症の治療薬
JP6003018B2 (ja)	2016-10-05	肝保護剤、医薬組成物、および細胞等保護用組成物
JP6847511B2 (ja)	2021-03-24	脂肪蓄積抑制剤及びこれを含有する飲食品
KR20070068837A (ko)	2007-07-02	영실로부터 얻은 지방세포분화 억제용 활성 분획 조성물
Gallegos-infante et al.	2019	Quantitative Analysis of Vitamin C in Lime and Lemon in Vitro: Verification of Vitamin C on the Impairment of Ob...
WO2016073843A2 (fr)	2016-05-12	Expression activée de mtor et expression inhibée de la myostatine dans des cellules de muscle squelettique
JP2022015281A (ja)	2022-01-21	筋萎縮を阻害するための組成物
JP2016069355A (ja)	2016-05-09	骨代謝改善剤
WO2019172174A1 (fr)	2019-09-12	Matière alimentaire ayant un effet d'inhibition de la signalisation de rage